EXHIBIT 99.1

JOINT FILING AGREEMENT

The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Immunome, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.

Dated: February 4, 2025

Immunome Aggregator, LP


By:

Enavate Sciences GP, LLC

its

General Partner


By:

/s/ James P. Boylan

Name: James P. Boylan

Title: Manager


Enavate Sciences GP, LLC


By:

/s/ James P. Boylan

Name: James P. Boylan

Title: Manager




Grafico Azioni Immunome (NASDAQ:IMNM)
Storico
Da Feb 2025 a Mar 2025 Clicca qui per i Grafici di Immunome
Grafico Azioni Immunome (NASDAQ:IMNM)
Storico
Da Mar 2024 a Mar 2025 Clicca qui per i Grafici di Immunome